PDCD1 and cutaneous melanoma: A treatment for metastases is eagerly awaited: many different studies have tested anti-PD-1 and anti-CTLA-4 therapies in UM patients, but results have been unsatisfactory, especially in comparison with metastasized cutaneous melanoma, with very few complete or partial responses [13,33,34].